21 CFR §630.3
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
As used in this part and in part 610, subpart E, and part 640 of this chapter:
- (a)Blood means a product that is a fluid containing dissolved and suspended elements which was collected from the vascular system of a human.
- (b)Blood component means a product containing a part of blood separated by physical or mechanical means.
- (c)Donor means a person who: (1) Donates blood or blood components for transfusion or for further manufacturing use; or
- (2)Presents as a potential candidate for such donation.
- (d)Eligibility of a donor means the determination that the donor is qualified to donate blood and blood components.
- (e)Infrequent plasma donor means a donor who has:
- (f)Intimate contact with risk for a relevant transfusion-transmitted infection means having engaged in an activity that could result in the transfer of potentially infectious body fluids from one person to another.
- (g)Physician substitute means a trained and qualified person(s) who is:
- (1)A graduate of an education program for health care workers that includes clinical training;
- (2)Currently licensed or certified as a health care worker in the jurisdiction where the collection establishment is located;
- (3)Currently certified in cardiopulmonary resuscitation; and
- (4)Trained and authorized under State law, and/or local law when applicable, to perform the specified functions under the direction of the responsible physician.
- (h)Relevant transfusion-transmitted infection means:
- (1)Any of the following transfusion-transmitted infections:
- (i)Human immunodeficiency virus, types 1 and 2 (referred to, collectively, as HIV);
- (ii)Hepatitis B virus (referred to as HBV);
- (iii)Hepatitis C virus (referred to as HCV);
- (iv)Human T-lymphotropic virus, types I and II (referred to, collectively, as HTLV);
- (v)Treponema pallidum (referred to as syphilis);
- (vi)West Nile virus;
- (vii)Trypanosoma cruzi (referred to as Chagas disease);
- (viii)Creutzfeldt-Jakob disease (referred to as CJD);
- (ix)Variant Creutzfeldt-Jakob disease (referred to as vCJD); and
- (x)Plasmodium species (referred to as malaria).
- (2)A transfusion-transmitted infection not listed in paragraph (h)(1) of this section when the following conditions are met:
- (1)Any of the following transfusion-transmitted infections:
- (i)Responsible physician means an individual who is:
- (1)Licensed to practice medicine in the jurisdiction where the collection establishment is located;
- (2)Adequately trained and qualified to direct and control personnel and relevant procedures concerning the determination of donor eligibility; collection of blood and blood components; the immunization of a donor; and the return of red blood cells or other blood components to the donor during collection of blood component(s) by apheresis; and
- (3)Designated by the collection establishment to perform the activities described in paragraph (i)(2) of this section.
- (j)Suitability of the donation means a determination of whether the donation is acceptable for transfusion or for further manufacturing use.
- (k)Trained person means an individual, including a physician substitute, who is authorized under State law, and/or local law when applicable, and adequately instructed and qualified to perform the specified functions under the direction of the responsible physician.
- (l)Transfusion-transmitted infection means a disease or disease agent:
- (1)That could be fatal or life-threatening, could result in permanent impairment of a body function or permanent damage to a body structure, or could necessitate medical or surgical intervention to preclude permanent impairment of body function or permanent damage to a body structure; and
- (2)For which there may be a risk of transmission by blood or blood components, or by a blood derivative product manufactured from blood or blood components, because the disease or disease agent is potentially transmissible by that blood, blood component, or blood derivative product.